GI
IMCR icon

GAMMA Investing’s Immunocore IMCR Stock Holding History

GAMMA Investing’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$64.8K Buy
2,140
+220
+11% +$7.48K ﹤0.01% 2193
2026
Q2 		$61K Buy
1,920
+1,286
+203% +$38K ﹤0.01% 2166
2026
Q1 		$19.1K Sell
634
-242
-28% -$7.83K ﹤0.01% 2738
2025
Q4 		$30.4K Sell
876
-38
-4% -$1.34K ﹤0.01% 2384
2025
Q3 		$33.2K Buy
914
+311
+52% +$10.6K ﹤0.01% 2247
2025
Q2 		$18.9K Sell
603
-41
-6% -$1.27K ﹤0.01% 2485
2025
Q1 		$19.1K Buy
644
+85
+15% +$2.55K ﹤0.01% 2407
2024
Q4 		$16.5K Buy
559
+136
+32% +$4.3K ﹤0.01% 2367
2024
Q3 		$13.2K Buy
423
+265
+168% +$9.64K ﹤0.01% 2334
2024
Q2 		$5.36K Buy
158
+22
+16% +$1.12K ﹤0.01% 2548
2024
Q1 		$8.84K Buy
136
+97
+249% +$6.66K ﹤0.01% 2128
2023
Q4 		$2.82K Buy
+39
New +$2.03K ﹤0.01% 2468

Other funds holding IMCR

JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's IMCR Position: Q3 2026 in Review

GAMMA Investing increased its Immunocore (IMCR) stake by 11% in Q3 2026, buying an estimated $7.48K and bringing the position to 2,140 shares worth $64.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

GAMMA Investing first reported a position in IMCR in Q4 2023 and has held it in 12 quarters since. 4 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • GAMMA Investing held 2,140 shares of Immunocore worth $64.8K as of Q3 2026.
  • GAMMA Investing bought 220 Immunocore shares in Q3 2026, an estimated $7.48K.
  • Immunocore made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2193 holding.
  • GAMMA Investing first reported a position in Immunocore in Q4 2023 and has held it in 12 quarters since.
  • 4 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.